Highly sensitive quantitative estimation of genotoxic impurities from API and drug formulation using LC/MS/MS
Posters | 2014 | ShimadzuInstrumentation
LC/MS, LC/MS/MS, LC/QQQ
IndustriesPharma & Biopharma
ManufacturerShimadzu
Key wordsdrn, bhbnb, gti, genotoxic, estimation, api, formulation, impurities, drug, sensitive, dronedarone, highly, quantitative, graph, from, using, concentration, area, blank, esi, min, calibration, name, analysis, preparation, ppb, studies, simultaneous, indications, provision, mrm, average, calculated, positive, recovery, confirms, standard, developed, sample, toxicological, obtained, method, absence, retention, ingredients, mainly, literature, any, nexera, mode
Similar PDF
High Sensitivity Quantitation of Nitrosamine Genotoxic Impurities: LC-MS Analysis of Ranitidine Drug Product using the Waters ACQUITY UPLC I-Class/Xevo TQ-XS Tandem Quadrupole Mass Spectrometer
2020|Waters|Applications
[ APPLICATION NOTE ] High Sensitivity Quantitation of Nitrosamine Genotoxic Impurities: LC-MS Analysis of Ranitidine Drug Product using the Waters ACQUITY UPLC I-Class/Xevo TQ-XS Tandem Quadrupole Mass Spectrometer Mary Trudeau Lame and Lindsay Hatch Waters Corporation, Milford, MA, USA APPLICATION…
Key words
ndma, ndmaranitidine, ranitidinenitrosamine, nitrosaminedrug, drugnmba, nmbablank, blankndba, ndbandea, ndeandipa, ndipaproduct, productarea, areaxevo, xevoneipa, neipauplc, uplcimpurities
Highly Sensitive and Robust UPLC-MS/MS Quantification of Nitrosamine Impurities in Sartan and Ranitidine Drug Substances
2020|Waters|Posters
Highly Sensitive and Robust UPLC-MS/MS Quantification of Nitrosamine Impurities in Sartan and Ranitidine Drug Substances Mary Trudeau Lame , Lindsay Hatch, Dave Higton, Paul Rainville, and Gordon Fujimoto Waters Corporation, Milford, MA, USA 2. UPLC Chromatographic Separation of Nitrosamine Impurities…
Key words
blank, blankranitidine, ranitidinendma, ndmadrug, drugmilford, milfordndea, ndeagti, gtisartan, sartanneipa, neipandipa, ndipandba, ndbanitrosamine, nitrosamineimpurities, impuritieslorsartan, lorsartanformulation
Determination of Nitrosamines in Active Pharmaceutical Ingredients
2020|Agilent Technologies|Applications
Application Note Pharmaceutical Determination of Nitrosamines in Active Pharmaceutical Ingredients High flexibility and performance at lowest cost using the Agilent 1260 Infinity II Prime LC with the Agilent Ultivo LC/TQ for LC/MS analysis Author Edgar Naegele Agilent Technologies, Inc. Abstract…
Key words
accuracy, accuracynitrosamine, nitrosaminendba, ndbanitrosamines, nitrosaminesnmor, nmornmea, nmeandpa, ndpandea, ndeaultivo, ultivondma, ndmanpip, npipvalsartan, valsartanpharmaceutical, pharmaceuticalgti, gtinitroso
The Use of the ACQUITY QDa Detector for a Selective, Sensitive, and Robust Quantitative Method for a Potential Genotoxic Impurity
2015|Waters|Applications
The Use of the ACQUITY QDa Detector for a Selective, Sensitive, and Robust Quantitative Method for a Potential Genotoxic Impurity Janet Hammond Waters Corporation, Wilmslow, UK A P P L I C AT I O N B E N E…
Key words
acquity, acquityuplc, uplcqda, qdamanager, managerclass, classgti, gtiempower, empowermasslynx, masslynxapi, apidetector, detectorgenotoxic, genotoxicoptimised, optimisedsystem, systemmethod, methodfacility